Type 2 & other diabetes

The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada

Lancet Diabetes EndocrinolPublished Prospective cohort study

Authors' conclusion

Recovery of β-cell function is the dominant determinant of the remission of prediabetes, akin to its role in remission of diabetes but at an earlier point in the natural history of dysglycaemia.

Study context

Population
Women with prediabetes after pregnancy (visit 1), screened for GDM in pregnancy at Mount Sinai Hospital, Toronto, Canada, with a subsequent visit (visit 2) at 3 months, 1, 3 or 5 years postpartum787 screened
Participants
182 women
Exposure
Remission vs no remission of prediabetes
  • Remissionn = 100
  • No remissionn = 82reference
Outcome
Changes in log Matsuda index, HOMA-IR, ISSI-2 and IGI/FPI between visits as predictors of remission of prediabetes (logistic regression adjusted for clinical diabetes risk factors)
Follow-up
Visit 2 (median 13.0 months [11.8-27.9] postpartum)
Methodological detailssingle-centre, serial postpartum OGTTs, Enrolment Sept 22, 2003 to Nov 30, 2018, Visit 1 at median 3.5 months (IQR 3.0-12.3) postpartum
  • Single-centre
  • Serial postpartum OGTTs
  • Enrolment Sept 22, 2003 to Nov 30, 2018
  • Visit 1 at median 3.5 months (IQR 3.0-12.3) postpartum

Main finding

As reported in the abstract

Between-visit change as predictor of remission

Change in log ISSI-2, aOR

3.80 (1.53-9.41) (95% CI)

Change in log Matsuda index, aOR

2.28 (1.21-4.31) (95% CI)

Top-ranked predictor: change in log ISSI-2, change in model deviance

8.49

Second-ranked: change in log Matsuda index, change in model deviance

6.56

Observational data: associations, not effects.

Further findings

OutcomeRemissionNo remissionP value
ISSI-2 at baseline (visit 1)Higher with Remission · median576 (IQR 493–674)496 (IQR 391–600)P < 0.0004
Matsuda index at visit 2Higher with Remission5.8 (IQR 3.9–7.9)3.9 (IQR 2.6–6.7)P = 0.0004
ISSI-2 at visit 2Higher with Remission650 (IQR 563–820)478 (IQR 389–590)P < 0.0001
IGI/FPI at visit 2Higher with Remission1.9 (IQR 1.2–2.5)1.3 (IQR 0.8–2.0)P = 0.0002

Original publication

The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada. Lancet Diabetes Endocrinol. Published 11 August 2025. doi:10.1016/s2213-8587(25)00163-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.